Multiple motivational forces contribute to nicotine dependence

Nebraska Symposium on Motivation

Volumn 55, Issue , 2009, Pages 65-89

  Markou, Athina ^a   Paterson, Neil E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GANGLION STIMULATING AGENT; NICOTINE;

ANIMAL; AROUSAL; CONDITIONING; DRUG EFFECT; HUMAN; LEARNING; MOTIVATION; MOTOR ACTIVITY; PSYCHOLOGICAL ASPECT; RAT; REVIEW; REWARD; SMOKING; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ANIMALS; AROUSAL; ASSOCIATION LEARNING; CONDITIONING (PSYCHOLOGY); GANGLIONIC STIMULANTS; HUMANS; MOTIVATION; MOTOR ACTIVITY; NICOTINE; RATS; REWARD; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 58149464899     PISSN: 01467875     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78748-0_5     Document Type: Conference Paper

References (110)

1. Ahmed, S. H., Kenny, P. J., Koob, G. F., & Markou, A. (2002). Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nature Neuroscience, 5(7), 625-626. (Pubitemid 34742974)
2. al'Absi, M., Hatsukami, D., Davis, G. L., & Wittmers, L. E. (2004). Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug and Alcohol Dependence, 73(3), 267-278. (Pubitemid 38231038)
3. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Press.
4. Arnold, J. M., & Roberts, D. C. S. (1997). A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacology Biochemistry and Behavior, 57(3), 441-447. (Pubitemid 27296755)
5. Baldwin, H. A., & Koob, G. F. (1993). Rapid induction of conditioned opiate withdrawal in the rat. Neuropsychopharmacology, 8(1), 15-21. (Pubitemid 23011154)
6. Balfour, D. J., Wright, A. E., Benwell, M. E., & Birrell, C. E. (2000). The putative role of extrasynaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behavioural Brain Research, 113(1-2), 73-83. (Pubitemid 30645545)
7. Bardo, M. T., Green, T. A., Crooks, P. A., & Dwoskin, L. P. (1999). Nornicotine is self-administered intravenously by rats. Psychopharmacology (Berl), 146(3), 290-296. (Pubitemid 29480240)
8. Benowitz, N. L., & Jacob, P., 3rd. (1984). Daily intake of nicotine during cigarette smoking. Clinical Pharmacology and Therapeutics, 35(4), 499-504. (Pubitemid 14133490)
9. Bozarth, M. A., Pudiak, C. M., & KuoLee, R. (1998). Effect of chronic nicotine on brain stimulation reward. II. An escalating dose regimen. Behavioural Brain Research, 96(1-2), 189-194. (Pubitemid 28494136)
10. Bruijnzeel, A. W., Zislis, G., Wilson, C., & Gold, M. S. (2007). Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology, 32(4), 955-963. (Pubitemid 46426186)
11. Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., et al. (2002). Environmental stimuli promote the acquisition of nicotine self-administration in rats. Psychopharmacology (Berl), 163(2), 230-237. (Pubitemid 35013615)
12. Caine, S. B., & Koob, G. F. (1995). Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behavioural Pharmacology, 6(4), 333-347.
13. Carboni, E., Bortone, L., Giua, C., & Di Chiara, G. (2000). Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. Drug and Alcohol Dependence, 58(1-2), 93-102.
14. Centers for Disease Control and Prevention (2005). Cigarette smoking among adults-United States, 2004. Morbidity and Mortality Weekly Report, 54(44), 1121-1124.
15. Chaudhri, N., Caggiula, A. R., Donny, E. C., Palmatier, M. I., Liu, X., & Sved, A. F. (2006). Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl), 184(3-4), 353-366. (Pubitemid 43255852)
16. Chiamulera, C., Borgo, C., Falchetto, S., Valerio, E., & Tessari, M. (1996). Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology (Berl), 127(2), 102-107. (Pubitemid 26298006)
17. Corrigall, W. A. (1999). Nicotine self-administration in animals as a dependence model. Nicotine and Tobacco Research, 1(1), 11-20.
18. Corrigall, W. A., & Coen, K. M. (1989). Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl), 99(4), 473-478. (Pubitemid 19273101)
19. Crooks, P. A., & Dwoskin, L. P. (1997). Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Biochemical Pharmacology, 54(7), 743-753. (Pubitemid 27404675)
20. Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003). Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology (Berl), 168(3), 347-358. (Pubitemid 36920920)
21. Damaj, M. I., Kao, W., & Martin, B. R. (2003). Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. Journal of Pharmacology and Experimental Therapeutics, 307(2), 526-534. (Pubitemid 37310665)
22. DeNoble, V. J., & Mele, P. C. (2006). Intravenous nicotine self-administration in rats: Effects of mecamylamine, hexamethonium and naloxone. Psychopharmacology (Berl), 184(3-4), 266-272. (Pubitemid 43255842)
23. Depoortere, R. Y., Li, D. H., Lane, J. D., & Emmett-Oglesby, M. W. (1993). Parameters of selfadministration of cocaine in rats under a progressive-ratio schedule. Pharmacology Biochemistry and Behavior, 45(3), 539-548.
24. Di Chiara, G. (2002). Nucleus accumbens shell and core dopamine: Differential role in behavior and addiction. Behavioural Brain Research, 137(1-2), 75-114. (Pubitemid 35346430)
25. Donny, E. C., Caggiula, A. R., Knopf, S., & Brown, C. (1995). Nicotine self-administration in rats. Psychopharmacology (Berl), 122(4), 390-394. (Pubitemid 26009997)
26. Donny, E. C., Caggiula, A. R., Mielke, M. M., Booth, S., Gharib, M. A., Hoffman, A., et al. (1999). Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology (Berl), 147(2), 135-142. (Pubitemid 30010560)
27. Dwoskin, L. P., Teng, L., Buxton, S. T., & Crooks, P. A. (1999). (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner. Journal of Pharmacology and Experimental Therapeutics, 288(3), 905-911. (Pubitemid 29254125)
28. Engberg, G., & Hajos, M. (1994). Nicotine-induced activation of locus coeruleus neurons: an analysis of peripheral versus central induction. Naunyn Schmiedeberg's Archives of Pharmacology, 349(5), 443-446. (Pubitemid 24135123)
29. Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998). Dramatic decreases in brain reward function during nicotine withdrawal. Nature, 393(6680), 76-79. (Pubitemid 28240257)
30. Fiore, M. C., Smith, S. S., Jorenby, D. E., & Baker, T. B. (1994). The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. Journal of the American Medical Association, 271(24), 1940-1947.
31. Geyer, M. A., & Markou, A. (1995). Animal models of psychiatric disorders. In: Psychopharmacology: The Fourth Generation of Progress.: Raven Press New York, NY. pp 787-798.
32. Glassman, A. H., Helzer, J. E., Covey, L. S., Cottler, L. B., Stetner, F., Tipp, J. E., et al. (1990). Smoking, smoking cessation, and major depression. Journal of the American Medical Association, 264(12), 1546-1549. (Pubitemid 20303384)
33. Goldberg, S. R., & Schuster, C. R. (1967). Conditioned suppression by a stimulus associated with nalorphine in morphine-dependent monkeys. Journal of the Experimental Analysis of Behavior, 10(3), 235-242.
34. Goldberg, S. R., Spealman, R. D., & Goldberg, D. M. (1981). Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science, 214(4520), 573-575. (Pubitemid 12206158)
35. Gosling, J. A., & Lu, T. C. (1969). Uptake and distribution of some quaternary ammonium compounds in the central nervous system of the rat. Journal of Pharmacology and Experimental Therapeutics, 167(1), 56-62.
36. Grottick, A. J., & Higgins, G. A. (2000). Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behavioural Brain Research, 117(1-2), 197-208.
37. Harrison, A. A., Gasparini, F., & Markou, A. (2002). Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology (Berl), 160(1), 56-66. (Pubitemid 34169826)
38. Harrison, A. A., Liem, Y. T., & Markou, A. (2001). Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology, 25(1), 55-71. (Pubitemid 32493822)
39. Hellemans, K. G., Dickinson, A., & Everitt, B. J. (2006). Motivational control of heroin seeking by conditioned stimuli associated with withdrawal and heroin taking by rats. Behavioral Neuroscience, 120(1), 103-114. (Pubitemid 43345108)
40. Hildebrand, B. E., Nomikos, G. G., Bondjers, C., Nisell, M., & Svensson, T. H. (1997). Behavioral manifestations of the nicotine abstinence syndrome in the rat: Peripheral versus central mechanisms. Psychopharmacology (Berl), 129(4), 348-356. (Pubitemid 27092998)
41. Hildebrand, B. E., Nomikos, G. G., Hertel, P., Schilstrom, B., & Svensson, T. H. (1998). Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Brain Research, 779(1-2), 214-225. (Pubitemid 28039954)
42. Hughes, J. R., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43(3), 289-294. (Pubitemid 16052281)
43. Hutcheson, D. M., Everitt, B. J., Robbins, T.W., & Dickinson, A. (2001). The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nature Neuroscience, 4(9), 943-947. (Pubitemid 32801599)
44. Irvine, E. E., Cheeta, S., & File, S. E. (2001). Tolerance to nicotine's effects in the elevated plusmaze and increased anxiety during withdrawal. Pharmacology Biochemistry and Behavior, 68(2), 319-325. (Pubitemid 32231194)
45. Jones, G. M., Sahakian, B. J., Levy, R., Warburton, D. M., & Gray, J. A. (1992). Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl), 108(4), 485-494.
46. Kenny, P. J., Chen, S. A., Kitamura, O.,Markou, A., & Koob, G. F. (2006). Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. Journal of Neuroscience, 26(22), 5894-5900. (Pubitemid 44318354)
47. Kenny, P. J., Gasparini, F., & Markou, A. (2003). Group II metabotropic and α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. Journal of Pharmacology and Experimental Therapeutics, 306(3), 1068-1076. (Pubitemid 37025315)
48. Kenny, P. J., Koob, G. F., & Markou, A. (2003). Conditioned facilitation of brain reward function after repeated cocaine administration. Behavioral Neuroscience, 117(5), 1103-1107. (Pubitemid 37243792)
49. Kenny, P. J., & Markou, A. (2001). Neurobiology of the nicotine withdrawal syndrome. Pharmacology Biochemistry and Behavior, 70(4), 531-549. (Pubitemid 34131647)
50. Kenny, P. J., & Markou, A. (2005). Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems. Journal of Neuroscience, 25(26), 6208-6212. (Pubitemid 40923487)
51. Kenny, P. J., & Markou, A. (2006). Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology, 31(6), 1203-1211. (Pubitemid 43971837)
52. Koob, G. F., & Le Moal, M. (2005). Neurobiology of Addiction. London: Academic Press.
53. LeSage, M. G., Burroughs, D., Dufek, M., Keyler, D. E., & Pentel, P. R. (2004). Reinstatement of nicotine self-administration in rats by presentation of nicotine-paired stimuli, but not nicotine priming. Pharmacology Biochemistry and Behavior, 79(3), 507-513. (Pubitemid 39576168)
54. LeSage, M. G., Keyler, D. E., Shoeman, D., Raphael, D., Collins, G., & Pentel, P. R. (2002). Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine. Pharmacology Biochemistry and Behavior, 72(1-2), 279-289. (Pubitemid 34251337)
55. Levin, E. D., Conners, C. K., Silva, D., Hinton, S. C., Meck, W. H., March, J., et al. (1998). Transdermal nicotine effects on attention. Psychopharmacology (Berl), 140(2), 135-141. (Pubitemid 28538472)
56. Levin, E. D., & Rezvani, A. H. (2002). Nicotinic treatment for cognitive dysfunction. Current Drug Targets. CNS and Neurological Disorders, 1(4), 423-431.
57. Levin, E. D., & Simon, B. B. (1998). Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl), 138(3-4), 217-230. (Pubitemid 28365487)
58. Lindblom, N., de Villiers, S. H., Semenova, S., Kalayanov, G., Gordon, S., Schilstrom, B., et al. (2005). Active immunisation against nicotine blocks the reward facilitating effects of nicotine and partially prevents nicotine withdrawal in the rat as measured by dopamine output in the nucleus accumbens, brain reward thresholds and somatic signs. Naunyn-Schmiedeberg's Archives of Pharmacology, 372(3), 182-194. (Pubitemid 41668748)
59. Liu, X., Caggiula, A. R., Yee, S. K., Nobuta, H., Poland, R. E., & Pechnick, R. N. (2006). Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats. Psychopharmacology (Berl), 184(3-4), 417-425. (Pubitemid 43255858)
60. Malin, D. H., Lake, J. R., Carter, V. A., Cunningham, J. S., Hebert, K. M., Conrad, D. L., et al. (1994). The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology (Berl), 115(1-2), 180-184. (Pubitemid 24207780)
61. Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., et al. (1992). Rodent model of nicotine abstinence syndrome. Pharmacology Biochemistry and Behavior, 43(3), 779-784.
62. Malin, D. H., Lake, J. R., Payne, M. C., Short, P. E., Carter, V. A., Cunningham, J. S., et al. (1996). Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible. Pharmacology Biochemistry and Behavior, 53(1), 81-85. (Pubitemid 26117737)
63. Malin, D. H., Lake, J. R., Schopen, C. K., Kirk, J. W., Sailer, E. E., Lawless, B. A., et al. (1997). Nicotine abstinence syndrome precipitated by central but not peripheral hexamethonium. Pharmacology Biochemistry and Behavior, 58(3), 695-699. (Pubitemid 27438126)
64. Markou, A., & Kenny, P. J. (2002). Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. Neurotoxicology Research, 4(4), 297-313.
65. Markou, A., & Koob, G. F. (1991). Postcocaine anhedonia: An animal model of cocaine withdrawal. Neuropsychopharmacology, 4(1), 17-26.
66. Markou, A., & Koob, G. F. (1992). Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiology and Behavior, 51(1), 111-119.
67. Markou, A., Kosten, T. R., & Koob, G. F. (1998). Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology, 18(3), 135-174. (Pubitemid 28062580)
68. Markou, A., & Paterson, N. E. (2001). The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine and Tobacco Research, 3(4), 361-373. (Pubitemid 33101063)
69. Markou, A., Weiss, F., Gold, L. H., Caine, S. B., Schulteis, G., & Koob, G. F. (1993). Animal models of drug craving. Psychopharmacology (Berl), 112(2-3), 163-182. (Pubitemid 23278275)
70. McGregor, A., & Roberts, D. C. S. (1995). Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement. Behavioural Brain Research, 67(1), 75-80.
71. Mirza, N. R., & Stolerman, I. P. (1998). Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology (Berl), 138(3-4), 266-274. (Pubitemid 28365491)
72. Murrin, L. C., Ferrer, J. R., Zeng, W. Y., & Haley, N. J. (1987). Nicotine administration to rats: Methodological considerations. Life Sciences, 40(17), 1699-1708. (Pubitemid 17055482)
73. O'Brien, C. P., Testa, T., O'Brien, T. J., Brady, J. P., & Wells, B. (1977). Conditioned narcotic withdrawal in humans. Science, 195(4282), 1000-1002. (Pubitemid 8081921)
74. Olds, J., & Milner, P. (1954). Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. Journal of Comparative and Physiological Psychology, 47(6), 419-427.
75. Parrott, A. C. (1993). Cigarette smoking: effects upon self-rated stress and arousal over the day. Addictive Behaviors, 18(4), 389-395. (Pubitemid 23253868)
76. Paterson, N. E., Balfour, D. J., & Markou, A. (2007). Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. European Journal of Neuroscience, 25(10), 3099-3108. (Pubitemid 46888800)
77. Paterson, N. E., Bruijnzeel, A. W., Kenny, P. J., Wright, C. D., Froestl, W., & Markou, A. (2005). Prolonged nicotine exposure does not alter GABAB receptor-mediated regulation of brain reward function. Neuropharmacology, 49(7), 953-962. (Pubitemid 41503295)
78. Paterson, N. E., Froestl, W., & Markou, A. (2004). The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl), 172(2), 179-186. (Pubitemid 38388767)
79. Paterson, N. E., Froestl,W., & Markou, A. (2005). Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats. Neuropsychopharmacology, 30(1), 119-128. (Pubitemid 40024406)
80. Paterson, N. E., & Markou, A. (2003). Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport, 14(17), 2229-2232.
81. Paterson, N. E., & Markou, A. (2004). Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Psychopharmacology (Berl), 173(1-2), 64-72. (Pubitemid 38591148)
82. Paterson, N. E., Myers, C., & Markou, A. (2000). Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology (Berl), 152(4), 440-446.
83. Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., & Baker, T. B. (2003). Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. Journal of Abnormal Psychology, 112(1), 14-27.
84. 2 subunit are involved in the reinforcing properties of nicotine. Nature, 391(6663), 173-177. (Pubitemid 28092475)
85. Pickens, R., & Thompson, T. (1968). Cocaine-reinforced behavior in rats: Effects of reinforcement magnitude and fixed-ratio size. Journal of Pharmacology and Experimental Therapeutics, 161(1), 122-129.
86. Risner, M. E., & Goldberg, S. R. (1983). A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion. Journal of Pharmacology and Experimental Therapeutics, 224(2), 319-326. (Pubitemid 13139084)
87. Rose, J. E. (2006). Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology (Berl), 184(3-4), 274-285. (Pubitemid 43255844)
88. Rowlett, J. K. (2000). A labor-supply analysis of cocaine self-administration under progressiveratio schedules: antecedents, methodologies, and perspectives. Psychopharmacology (Berl), 153(1), 1-16. (Pubitemid 32127900)
89. Sacco, K. A., Termine, A., Seyal, A., Dudas, M. M., Vessicchio, J. C., Krishnan-Sarin, S., et al. (2005). Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Archives of General Psychiatry, 62(6), 649-659. (Pubitemid 40973440)
90. Sannerud, C. A., Prada, J., Goldberg, D. M., & Goldberg, S. R. (1994). The effects of sertraline on nicotine self-administration and food-maintained responding in squirrel monkeys. European Journal of Pharmacology, 271(2-3), 461-469.
91. Schulteis, G., Markou, A., Cole, M., & Koob, G. F. (1995). Decreased brain reward produced by ethanol withdrawal. Proceedings of the National Academy of Sciences of the United States of America, 92(13), 5880-5884.
92. Schulteis, G., Markou, A., Gold, L. H., Stinus, L., & Koob, G. F. (1994). Relative sensitivity to naloxone of multiple indices of opiate withdrawal: A quantitative dose-response analysis. Journal of Pharmacology and Experimental Therapeutics, 271(3), 1391-1398. (Pubitemid 24382650)
93. See, R. E., Grimm, J. W., Kruzich, P. J., & Rustay, N. (1999). The importance of a compound stimulus in conditioned drug-seeking behavior following one week of extinction from selfadministered cocaine in rats. Drug and Alcohol Dependence, 57(1), 41-49. (Pubitemid 29452954)
94. Semenova, S., & Markou, A. (2003). Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine. Biological Psychiatry, 54(11), 1249-1264. (Pubitemid 37464871)
95. Semenova, S., Stolerman, I. P., & Markou, A. (2007). Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats. Pharmacology Biochemistry and Behavior, 87(3), 360-368. (Pubitemid 47101880)
96. Shaham, Y., Adamson, L. K., Grocki, S., & Corrigall, W. A. (1997). Reinstatement and spontaneous recovery of nicotine seeking in rats. Psychopharmacology (Berl), 130(4), 396-403. (Pubitemid 27179734)
97. Shaham, Y., Shalev, U., Lu, L., De Wit, H., & Stewart, J. (2003). The reinstatement model of drug relapse: History, methodology andmajor findings. Psychopharmacology (Berl),168(1-2), 3-20. (Pubitemid 36851158)
98. Shoaib, M., & Bizarro, L. (2005). Deficits in a sustained attention task following nicotine withdrawal in rats. Psychopharmacology (Berl), 178(2-3), 211-222. (Pubitemid 40379216)
99. Shoaib, M., & Stolerman, I. P. (1999). Plasma nicotine and cotinine levels following intravenous nicotine self-administration in rats. Psychopharmacology (Berl), 143(3), 318-321. (Pubitemid 29204988)
100. Skjei, K. L., & Markou, A. (2003). Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats. Psychopharmacology (Berl), 168(3), 280-292. (Pubitemid 36920911)
101. Smolka, M. N., Budde, H., Karow, A. C., & Schmidt, L. G. (2004). Neuroendocrinological and neuropsychological correlates of dopaminergic function in nicotine dependence. Psychopharmacology (Berl), 175(3), 374-381. (Pubitemid 39361926)
102. Snyder, F. R., & Henningfield, J. E. (1989). Effects of nicotine administration following 12 h of tobacco deprivation: assessment on computerized performance tasks. Psychopharmacology (Berl), 97(1), 17-22. (Pubitemid 19020376)
103. Spielewoy, C., & Markou, A. (2003). Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function. Neuropsychopharmacology, 28(6), 1106-1116.
104. Stolerman, I. P., & Jarvis, M. J. (1995). The scientific case that nicotine is addictive. Psychopharmacology (Berl), 117(1), 2-10; discussion 14-20.
105. Suzuki, T., Ise, Y., Tsuda, M., Maeda, J., & Misawa, M. (1996). Mecamylamine-precipitated nicotine-withdrawal aversion in rats. European Journal of Pharmacology, 314(3), 281-284. (Pubitemid 26382429)
106. Taylor, J. R., & Robbins, T. W. (1984). Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology (Berl), 84(3), 405-412. (Pubitemid 15205970)
107. Valentine, J. D., Hokanson, J. S., Matta, S. G., & Sharp, B. M. (1997). Self-administration in rats allowed unlimited access to nicotine. Psychopharmacology (Berl), 133(3), 300-304. (Pubitemid 27445664)
108. Watkins, S. S., Epping-Jordan,M. P., Koob, G. F., & Markou, A. (1999). Blockade of nicotine selfadministration with nicotinic antagonists in rats. Pharmacology Biochemistry and Behavior, 62(4), 743-751. (Pubitemid 29127180)
109. Watkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000). Reward and somatic changes during precipitated nicotine withdrawal in rats: Centrally and peripherally mediated effects. Journal of Pharmacology and Experimental Therapeutics, 292(3), 1053-1064. (Pubitemid 30136601)
110. West, R. J., Jarvis, M. J., Russell, M. A., Carruthers, M. E., & Feyerabend, C. (1984). Effect of nicotine replacement on the cigarette withdrawal syndrome. British Journal of Addiction, 79(2), 215-219. (Pubitemid 15159763)